Metabolic regulation of NLRP3

Immunological Reviews

Volumn 281, Issue 1, 2018, Pages 88-98

  Hughes, Mark M ^a   O’Neill, Luke A J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Glycolysis; Inflammasome; Inflammation; Krebs cycle; Metabolism; NLRP3

Indexed keywords

CRYOPYRIN; HEXOKINASE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PKM2 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; CHOLESTEROL; INFLAMMASOME; INTERLEUKIN 1BETA CONVERTING ENZYME; KETONE BODY; PALMITIC ACID; REACTIVE OXYGEN METABOLITE; URIC ACID;

AGING; GLYCOLYSIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID METABOLISM; METABOLIC REGULATION; MITOCHONDRION; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; ANIMAL; MACROPHAGE; METABOLISM; PHYSIOLOGY; PYROPTOSIS;

ANIMALS; CASPASE 1; CELLULAR REPROGRAMMING; CHOLESTEROL; HEXOKINASE; HUMANS; INFLAMMASOMES; KETONE BODIES; MACROPHAGES; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; PALMITIC ACID; PYROPTOSIS; REACTIVE OXYGEN SPECIES; URIC ACID;

EID: 85037994658     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12608     Document Type: Review

References (86)

1. Chavez-Sanchez L, Espinosa-Luna JE, Chavez-Rueda K, et al. Innate immune system cells in atherosclerosis. Arch Med Res. 2014;45:1-14. https://doi.org/10.1016/j.arcmed.2013.11.007.
2. Lee J. Adipose tissue macrophages in the development of obesity- induced inflammation, insulin resistance and type 2 diabetes. Arch Pharm Res. 2013;36:208-222. https://doi.org/10.1007/s12272-013-0023-8.
3. Minciullo PL, Catalano A, Mandraffino G, et al. Inflammaging and anti-inflammaging: the role of cytokines in extreme longevity. Arch Immunol Ther Exp (Warsz). 2016;64:111-126. https://doi.org/10.1007/s00005-015-0377-3.
4. Johnson AR, Milner JJ, Makowski L. The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev. 2012;249:218-238. https://doi.org/10.1111/j.1600-065X.2012.01151.x.
5. Chimenti MS, Triggianese P, Conigliaro P, et al. The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis. 2015;6:e1887. https://doi.org/10.1038/cddis.2015.246.
6. Lu A, Magupalli VG, Ruan J, et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell. 2014;156:1193-1206. https://doi.org/10.1016/j.cell.2014.02.008.
7. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10:417-426.
8. Agostini L, Martinon F, Burns K, et al. NALP3 forms an IL-1beta- processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004;20:319-325.
9. Zhou R, Tardivel A, Thorens B, et al. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010;11:136-140. https://doi.org/10.1038/ni.1831.
10. Vandanmagsar B, Youm YH, Ravussin A, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17:179-188. https://doi.org/10.1038/nm.2279.
11. Gaidt MM, Ebert TS, Chauhan D, et al. Human monocytes engage an alternative inflammasome pathway. Immunity. 2016;44:833-846. https://doi.org/10.1016/j.immuni.2016.01.012.
12. Kayagaki N, Warming S, Lamkanfi M, et al. Non-canonical inflammasome activation targets caspase-11. Nature. 2011;479:117-121. https://doi.org/10.1038/nature10558.
13. Kayagaki N, Stowe IB, Lee BL, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526:666-671. https://doi.org/10.1038/nature15541.
14. Holmstrom KM, Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol. 2014;15:411-421. https://doi.org/10.1038/nrm3801.
15. Garcia-Santamarina S, Boronat S, Hidalgo E. Reversible cysteine oxidation in hydrogen peroxide sensing and signal transduction. Biochemistry. 2014;53:2560-2580. https://doi.org/10.1021/bi401700f.
16. Hughes MM, McGettrick AF, O’Neill LA. Glutathione and glutathione transferase omega 1 as key posttranslational regulators in macrophages. Microbiol Spectr. 2017;5:789-801. https://doi.org/10.1128/microbiolspec.MCHD-0044-2016.
17. Hughes MM, Lavrencic P, Coll RC, et al. Solution structure of the TLR adaptor MAL/TIRAP reveals an intact BB loop and supports MAL Cys91 glutathionylation for signaling. Proc Natl Acad Sci U S A. 2017;114:E6480-6489. https://doi.org/10.1073/pnas.1701868114.
18. Meissner F, Molawi K, Zychlinsky A. Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat Immunol. 2008;9:866-872. https://doi.org/10.1038/ni.1633.
19. Huang Z, Pinto JT, Deng H, et al. Inhibition of caspase-3 activity and activation by protein glutathionylation. Biochem Pharmacol. 2008;75:2234-2244. https://doi.org/10.1016/j.bcp.2008.02.026.
20. Guglielmo A, Sabra A, Elbery M, et al. A mechanistic insight into curcumin modulation of the IL-1beta secretion and NLRP3 S-glutathionylation induced by needle-like cationic cellulose nanocrystals in myeloid cells. Chem Biol Interact. 2017;274:1-12. https://doi.org/10.1016/j.cbi.2017.06.028.
21. Shi H, Wang Y, Li X, et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat Immunol. 2016;17:250-258. https://doi.org/10.1038/ni.3333.
22. He Y, Zeng MY, Yang D, et al. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 2016;530:354-357. https://doi.org/10.1038/nature16959.
23. Munoz-Planillo R, Kuffa P, Martinez-Colon G, et al. K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity. 2013;38:1142-1153. https://doi.org/10.1016/j.immuni.2013.05.016.
24. Domingo-Fernandez R, Coll RC, Kearney J, et al. The intracellular chloride channel proteins CLIC1 and CLIC4 induce IL-1beta transcription and activate the NLRP3 inflammasome. J Biol Chem. 2017;292:12077-12087. https://doi.org/10.1074/jbc.M117.797126.
25. Tang T, Lang X, Xu C, et al. CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation. Nat Commun. 2017;8:202. https://doi.org/10.1038/s41467-017-00227-x.
26. Cunha LD, Silva ALN, Ribeiro JM, et al. AIM2 engages active but unprocessed caspase-1 to induce noncanonical activation of the NLRP3 inflammasome. Cell Rep. 2017;20:794-805. https://doi.org/10.1016/j.celrep.2017.06.086.
27. Haneklaus M, O’Neil JD, Clark AR, et al. The RNA-binding protein Tristetraprolin (TTP) is a critical negative regulator of the NLRP3 inflammasome. J Biol Chem. 2017;292:6869-6881. https://doi.org/10.1074/jbc.M116.772947.
28. Lee SJ, Michel SL. Cysteine oxidation enhanced by iron in tristetraprolin, a zinc finger peptide. Inorg Chem. 2010;49:1211-1219. https://doi.org/10.1021/ic9024298.
29. Chen CY, Liaw CC, Chen YH, et al. A novel immunomodulatory effect of ugonin U in human neutrophils via stimulation of phospholipase C. Free Radic Biol Med. 2014;72:222-231. https://doi.org/10.1016/j.freeradbiomed.2014.04.018.
30. Chen CY, Yang CH, Tsai YF, et al. Ugonin U stimulates NLRP3 inflammasome activation and enhances inflammasome-mediated pathogen clearance. Redox Biol. 2017;11:263-274. https://doi.org/10.1016/j.redox.2016.12.018.
31. Moon JS, Lee S, Park MA, et al. UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis. J Clin Invest. 2015;125:665-680. https://doi.org/10.1172/jci78253.
32. Moon JS, Nakahira K, Chung KP, et al. NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages. Nat Med. 2016;22:1002-1012. https://doi.org/10.1038/nm.4153.
33. Tannahill GM, Curtis AM, Adamik J, et al. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature. 2013;496:238-242. https://doi.org/10.1038/nature11986.
34. Sanman LE, Qian Y, Eisele NA, et al. Disruption of glycolytic flux is a signal for inflammasome signaling and pyroptotic cell death. Elife. 2016;5:e13663. https://doi.org/10.7554/eLife.13663.
35. Moon JS, Hisata S, Park MA, et al. mTORC1-induced HK1-dependent glycolysis regulates NLRP3 inflammasome activation. Cell Rep. 2015;12:102-115. https://doi.org/10.1016/j.celrep.2015.05.046.
36. Nomura J, So A, Tamura M, et al. Intracellular ATP decrease mediates NLRP3 inflammasome activation upon nigericin and crystal stimulation. J Immunol. 2015;195:5718-5724. https://doi.org/10.4049/jimmunol.1402512.
37. Majewski N, Nogueira V, Bhaskar P, et al. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell. 2004;16:819-830. https://doi.org/10.1016/j.molcel.2004.11.014.
38. Hahn-Windgassen A, Nogueira V, Chen CC, et al. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J Biol Chem. 2005;280:32081-32089. https://doi.org/10.1074/jbc.M502876200.
39. Wolf AJ, Reyes CN, Liang W, et al. Hexokinase is an innate immune receptor for the detection of bacterial peptidoglycan. Cell. 2016;166:624-636. https://doi.org/10.1016/j.cell.2016.05.076.
40. Luo W, Hu H, Chang R, et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell. 2011;145:732-744. https://doi.org/10.1016/j.cell.2011.03.054.
41. Palsson-McDermott EM, Curtis AM, Goel G, et al. Pyruvate kinase M2 regulates Hif-1alpha activity and IL-1beta induction and is a critical determinant of the warburg effect in LPS-activated macrophages. Cell Metab. 2015;21:65-80. https://doi.org/10.1016/j.cmet.2014.12.005.
42. Xie M, Yu Y, Kang R, et al. PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation. Nat Commun. 2016;7:13280. https://doi.org/10.1038/ncomms13280.
43. Pasinelli P. Caspase-1 and -3 are sequentially activated in motor neuron death. Proc Natl Acad Sci U S A. 2000;97:13901-13906.
44. Youm YH, Grant RW, McCabe LR, et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 2013;18:519-532. https://doi.org/10.1016/j.cmet.2013.09.010.
45. Stienstra R, van Diepen JA, Tack CJ, et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A. 2011;108:15324-15329. https://doi.org/10.1073/pnas.1100255108.
46. Coll RC, Robertson AA, Chae JJ, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21:248-255. https://doi.org/10.1038/nm.3806.
47. Dinarello CA, Donath MY, Mandrup-Poulsen T. Role of IL-1beta in type 2 diabetes. Curr Opin Endocrinol Diabetes Obes. 2010;17:314-321. https://doi.org/10.1097/MED.0b013e32833bf6dc.
48. Hill JR, Coll RC, Sue N, et al. Sulfonylureas as concomitant insulin secretagogues and NLRP3 inflammasome inhibitors. ChemMedChem. 2017;12:1449-1457. https://doi.org/10.1002/cmdc.201700270.
49. McBride MJ, Foley KP, D’Souza DM, et al. The NLRP3 inflammasome contributes to sarcopenia and lower muscle glycolytic potential in old mice. Am J Physiol Endocrinol Metab. 2017;313:E222-e232. https://doi.org/10.1152/ajpendo.00060.2017.
50. Shao W, Yeretssian G, Doiron K, et al. The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J Biol Chem. 2007;282:36321-36329. https://doi.org/10.1074/jbc.M708182200.
51. Wen H, Gris D, Lei Y, et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol. 2011;12:408-415. https://doi.org/10.1038/ni.2022.
52. Youm YH, Nguyen KY, Grant RW, et al. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. 2015;21:263-269. https://doi.org/10.1038/nm.3804.
53. Kong G, Huang Z, Ji W, et al. The ketone metabolite beta-hydroxybutyrate attenuates oxidative stress in spinal cord injury by suppression of class I histone deacetylases. J Neurotrauma. 2017;34:2645-2655. https://doi.org/10.1089/neu.2017.5192.
54. Yamanashi T, Iwata M, Kamiya N, et al. Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses. Sci Rep. 2017;7:7677. https://doi.org/10.1038/s41598-017-08055-1.
55. Goldberg EL, Asher JL, Molony RD, et al. beta-Hydroxybutyrate deactivates neutrophil NLRP3 inflammasome to relieve gout flares. Cell Rep. 2017;18:2077-2087. https://doi.org/10.1016/j.celrep.2017.02.004.
56. Bakker PJ, Butter LM, Kors L, et al. Nlrp3 is a key modulator of diet-induced nephropathy and renal cholesterol accumulation. Kidney Int. 2014;85:1112-1122. https://doi.org/10.1038/ki.2013.503.
57. Chiang JY. Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J Hepatol. 2004;40:539-551. https://doi.org/10.1016/j.jhep.2003.11.006.
58. Guo C, Xie S, Chi Z, et al. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity. 2016;45:944. https://doi.org/10.1016/j.immuni.2016.10.009.
59. Sokolowska M, Chen LY, Liu Y, et al. Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cyclic AMP in human macrophages. J Immunol. 2015;194:5472-5487. https://doi.org/10.4049/jimmunol.1401343.
60. Zaslona Z, Palsson-McDermott EM, Menon D, et al. The induction of Pro-IL- 1beta by lipopolysaccharide requires endogenous prostaglandin E2 production. J Immunol. 2017;198:3558-3564. https://doi.org/10.4049/jimmunol.1602072.
61. Kelly B, Tannahill GM, Murphy MP, et al. Metformin inhibits the production of reactive oxygen species from NADH: ubiquinone oxidoreductase to limit induction of interleukin-1beta (IL-1beta) and boosts interleukin-10 (IL-10) in lipopolysaccharide (LPS)-activated macrophages. J Biol Chem. 2015;290:20348-20359. https://doi.org/10.1074/jbc.M115.662114.
62. Mills EL, Kelly B, Logan A, et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell. 2016;167:457-470. https://doi.org/10.1016/j.cell.2016.08.064.
63. Shimada K, Crother TR, Karlin J, et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity. 2012;36:401-414. https://doi.org/10.1016/j.immuni.2012.01.009.
64. Li Y, Zheng JY, Liu JQ, et al. Succinate/NLRP3 inflammasome induces synovial fibroblast activation: therapeutical effects of clematichinenoside AR on arthritis. Front Immunol. 2016;7:532. https://doi.org/10.3389/fimmu.2016.00532.
65. Liu X, Zhou W, Zhang X, et al. Dimethyl fumarate ameliorates dextran sulfate sodium-induced murine experimental colitis by activating Nrf2 and suppressing NLRP3 inflammasome activation. Biochem Pharmacol. 2016;112:37-49. https://doi.org/10.1016/j.bcp.2016.05.002.
66. Zhao Y, Yang J, Shi J, et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature. 2011;477:596-600. https://doi.org/10.1038/nature10510.
67. Matusiak M, Van Opdenbosch N, Vande Walle L, et al. Flagellin-induced NLRC4 phosphorylation primes the inflammasome for activation by NAIP5. Proc Natl Acad Sci U S A. 2015;112:1541-1546. https://doi.org/10.1073/pnas.1417945112.
68. Broz P, Newton K, Lamkanfi M, et al. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J Exp Med. 2010;207:1745-1755. https://doi.org/10.1084/jem.20100257.
69. Wynosky-Dolfi MA, Snyder AG, Philip NH, et al. Oxidative metabolism enables Salmonella evasion of the NLRP3 inflammasome. J Exp Med. 2014;211:653-668. https://doi.org/10.1084/jem.20130627.
70. Lima-Junior DS, Mineo TWP, Calich VLG, et al. Dectin-1 activation during Leishmania amazonensis phagocytosis prompts Syk-dependent reactive oxygen species production to trigger inflammasome assembly and restriction of parasite replication. J Immunol. 2017;199:2055-2068. https://doi.org/10.4049/jimmunol.1700258.
71. Dostert C, Petrilli V, Van Bruggen R, et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 2008;320:674-677. https://doi.org/10.1126/science.1156995.
72. Zhou R, Yazdi AS, Menu P, et al. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469:221-225. https://doi.org/10.1038/nature09663.
73. Iyer SS, He Q, Janczy JR, et al. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity. 2013;39:311-323. https://doi.org/10.1016/j.immuni.2013.08.001.
74. Park S, Juliana C, Hong S, et al. The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity. J Immunol. 2013;191:4358-4366. https://doi.org/10.4049/jimmunol.1301170.
75. Yu J, Nagasu H, Murakami T, et al. Inflammasome activation leads to Caspase-1- dependent mitochondrial damage and block of mitophagy. Proc Natl Acad Sci U S A. 2014;111:15514-15519. https://doi.org/10.1073/pnas.1414859111.
76. Heid ME, Keyel PA, Kamga C, et al. Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation. J Immunol. 2013;191:5230-5238. https://doi.org/10.4049/jimmunol.1301490.
77. Gross CJ, Mishra R, Schneider KS, et al. K+ efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria. Immunity. 2016;45:761-773. https://doi.org/10.1016/j.immuni.2016.08.010.
78. Ip WKE, Hoshi N, Shouval DS, et al. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science. 2017;356:513-519. https://doi.org/10.1126/science.aal3535.
79. Clarke K, Tchabanenko K, Pawlosky R, et al. Kinetics, safety and tolerability of (R)-3- hydroxybutyl (R)-3- hydroxybutyrate in healthy adult subjects. Regul Toxicol Pharmacol. 2012;63:401-408. https://doi.org/10.1016/j.yrtph.2012.04.008.
80. Kemper MF, Srivastava S, Todd King M, et al. An ester of beta-hydroxybutyrate regulates cholesterol biosynthesis in rats and a cholesterol biomarker in humans. Lipids. 2015;50:1185-1193. https://doi.org/10.1007/s11745-015-4085-x.
81. Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012;148:1145-1159. https://doi.org/10.1016/j.cell.2012.02.035.
82. Feng H, Gu J, Gou F, et al. High glucose and lipopolysaccharide prime NLRP3 Inflammasome via ROS/TXNIP pathway in mesangial cells. J Diabetes Res. 2016. https://doi.org/10.1155/2016/6973175
83. Tseng HH, Vong CT, Kwan YW, et al. TRPM2 regulates TXNIP-mediated NLRP3 inflammasome activation via interaction with p47 phox under high glucose in human monocytic cells. Sci Rep. 2016;6. https://doi.org/10.1038/srep35016
84. Wang C, Xu CX, Alippe Y, et al. Chronic inflammation triggered by the NLRP3 inflammasome in myeloid cells promotes growth plate dysplasia by mesenchymal cells. Sci Rep. 2017;7:4880. https://doi.org/10.1038/s41598-017-05033-5
85. Lampropoulou V, Sergushichev A, Bambouskova M, et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 2016;24:158-166. https://doi.org/10.1016/j.cmet.2016.06.004
86. Qin YY, Li M, Feng X, et al. Combined NADPH and the NOX inhibitor apocynin provides greater anti-inflammatory and neuroprotective effects in a mouse model of stroke. Free Radic Biol Med. 2017;104: 333-345. https://doi.org/10.1016/j.freeradbiomed.2017.01.034